Comparison of IFA and LIAISON® for Diagnosis of Early Disseminated Lyme Borreliosis in Children, Younger Than 18 Years
Comparison of Immunofluorescence Assay (IFA) and Chemiluminiscence Immunoassay (LIAISON®) for Diagnosis of Early Disseminated Lyme Borreliosis in Children, Younger Than 18 Years
1 other identifier
observational
349
1 country
1
Brief Summary
The aim of this study is to compare two different serological tests, IFA and LIAISON, for detection of Borrelia burgdorferi sensu lato IgM and IgG antibiodies in children with early disseminated Lyme borreliosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2018
CompletedFirst Posted
Study publicly available on registry
January 10, 2019
CompletedStudy Start
First participant enrolled
January 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedApril 30, 2021
April 1, 2021
1.9 years
December 17, 2018
April 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity IFA vs. LIAISON
LIAISON test (E/ml) is expected to be more sensitive than IFA (titer) in detection of Borrelial antibodies in children with early disseminated LB. In all patients both asseys (LIAISON and IFA) are going to be done from the same samples. The difference in the proportion of positive tests between the two assays will be statisticaly analyzed for IgM and IgG antibodies of each patient group. P values \< 0,05 will be interpreted as statistically significant. IFA: Titres \>256 in serum and \>4 in CSF will be considered positive. LIAISON values in serum: the values of IgM and IgG in serum \<18 in \<10 E/ml will be considered as negative, 18-22 and 10-15 E/ml will be considerd as border values and \>22 in \>15 E/ml will be considered as positive. LIAISON in cerebral fluid: the values of IgM in IgG in cerebral fluid \<2,5 and \<4,5 E/ml will be considered as negative, values 2,5-3,5 and 4,5-5,5 E/ml will be considered as border values and \>2,5 in \>5,5 E/ml will be considered as positive.
2 years
Interventions
Comparison of two diagnostic serological tests - IFA and LIAISON.
Eligibility Criteria
Younger then 18 years
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
University clinical center
Ljubljana, Slovenia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- izr. prof. dr. Maja Arnez, dr. med
Study Record Dates
First Submitted
December 17, 2018
First Posted
January 10, 2019
Study Start
January 29, 2019
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
April 30, 2021
Record last verified: 2021-04